{"id":27786,"date":"2025-09-09T15:56:18","date_gmt":"2025-09-09T22:56:18","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=27786"},"modified":"2025-09-09T15:56:20","modified_gmt":"2025-09-09T22:56:20","slug":"ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/","title":{"rendered":"IVIG \u6cbb\u7597 CAR-T \u7597\u6cd5\u76f8\u5173\u4f4e\u4e19\u79cd\u7403\u86cb\u767d\u8840\u75c7\uff1a\u7528\u9014\u3001\u76ca\u5904\u3001\u5242\u91cf\u53ca\u66f4\u591a\u4fe1\u606f"},"content":{"rendered":"\n<p>Clinicians often recommend <a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/ivig\/\">IVIG<\/a> for CAR-T therapy-related <a href=\"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/hypogammaglobulinemia\/\">hypogammaglobulinemia<\/a> to reduce infection risk and improve survival. However, these recommendations are slim and based on expert opinion and clinical trial results.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-4d1805a22799161c2dc76d485a795d73\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet IVIG Prior Authorization\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#A_Quick_Overview_of_CAR-T_Therapy\" >A Quick Overview of CAR-T Therapy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#What_Is_CAR-T_Therapy-Related_Hypogammaglobulinemia\" >What Is CAR-T Therapy-Related Hypogammaglobulinemia?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#Understanding_the_Mechanism_of_CAR-T_Therapy-Related_Hypogammaglobulinemia\" >Understanding the Mechanism of CAR-T Therapy-Related Hypogammaglobulinemia<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#When_To_Use_IVIG_for_CAR-T_Therapy-Related_Hypogammaglobulinemia\" >When To Use IVIG for CAR-T Therapy-Related Hypogammaglobulinemia<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#IVIG_for_CAR-T_Therapy-Related_Hypogammaglobulinemia_in_Children\" >IVIG for CAR-T Therapy-Related Hypogammaglobulinemia in Children<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#IVIG_for_CAR-T_Therapy-Related_Hypogammaglobulinemia_What_Are_the_Benefits\" >IVIG for CAR-T Therapy-Related Hypogammaglobulinemia: What Are the Benefits?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#Frequently_Asked_Questions\" >Frequently Asked Questions<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"A_Quick_Overview_of_CAR-T_Therapy\"><\/span>A Quick Overview of CAR-T Therapy<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>CAR-T therapy is an acronym for chimeric antigen receptor (CAR)-T cell therapy. A form of immunotherapy, CAR-T cell therapy is currently used to treat certain blood cancers. Immunotherapy for cancer enhances your immune system\u2019s ability to identify and destroy cancer cells.&nbsp;<\/p>\n\n\n\n<p>As the name suggests, CAR-T cell therapy uses the patient\u2019s own T cells. T cells or T lymphocytes are a type of white blood cell that primarily destroy bacteria, viruses, and cancer cells.&nbsp;<\/p>\n\n\n\n<p>CAR-T cell therapy involves the following steps:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>T cells are collected from a patient&#8217;s blood and sent to the lab.\u00a0<\/li>\n\n\n\n<li>In the lab, these cells are genetically modified to create special proteins called chimeric antigen receptors (CARs) on the cell surface.\u00a0<\/li>\n\n\n\n<li>The modified cells \u2014 CAR-T cells \u2014 are grown to millions in the lab.\u00a0<\/li>\n\n\n\n<li>Lastly, when there are enough of the modified cells, they are administered to the patient in a single infusion. Once in the patient\u2019s bloodstream, these cells identify and kill cancer cells.\u00a0<\/li>\n<\/ol>\n\n\n\n<p>The entire process, from collection to reinfusion, takes about 4 weeks.&nbsp;<\/p>\n\n\n\n<p>Examples of FDA-approved CAR-T cell therapy include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Yescarta<\/li>\n\n\n\n<li>Kymriah<\/li>\n\n\n\n<li>Tecartus<\/li>\n\n\n\n<li>Carvykti<\/li>\n\n\n\n<li>Abecma<\/li>\n\n\n\n<li>Breyanzi<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_CAR-T_Therapy-Related_Hypogammaglobulinemia\"><\/span>What Is CAR-T Therapy-Related Hypogammaglobulinemia?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Hypogammaglobulinemia is when immunoglobulin G (IgG) levels drop too low, increasing a person\u2019s risk of getting potentially life-threatening bacterial, viral, or fungal infections.&nbsp;<\/p>\n\n\n\n<p>CAR-T therapy-related hypogammaglobulinemia is common and expected during or after CAR-T therapy. It can occur a few weeks after infusion and last months or even years. Studies show that children are more likely than adults to get CAR-T therapy-related hypogammaglobulinemia [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8837681\/\">1<\/a>].<\/p>\n\n\n\n<p>The definitions of CAR-T therapy-related hypogammaglobulinemia can vary. Nevertheless, hypogammaglobulinemia is typically confirmed if the serum IgG levels fall below 400 mg\/dl. Hypogammaglobulinemia may be classified as [<a href=\"https:\/\/www.jacionline.org\/article\/S0091-6749%2820%2931817-0\/fulltext\">2<\/a>]:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mild<\/strong> (IgG &lt; 650 mg\/dL)<\/li>\n\n\n\n<li><strong>Moderate<\/strong> (IgG &lt; 400 mg\/dL)<\/li>\n\n\n\n<li><strong>Severe<\/strong> (IgG &lt; 200 mg\/dL)<\/li>\n<\/ul>\n\n\n\n<p>Several factors determine the occurrence, severity, and duration of hypogammaglobulinemia and infections. These include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Product type<\/li>\n\n\n\n<li>Age of the patient<\/li>\n\n\n\n<li><a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/what-are-the-normal-igg-levels-by-age\/\">IgG levels<\/a> before starting CAR-T therapy<\/li>\n\n\n\n<li>Use of chemotherapy during the CAR-T cell manufacturing period (the period between T cell collection and reinfusion of modified T cells)<\/li>\n\n\n\n<li>Type of cancer being treated<\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-9ed2611a8c75f4b7f2ffce3fd60c5749\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tAsk About IVIG Home Infusion\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Schedule a Consultation<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Understanding_the_Mechanism_of_CAR-T_Therapy-Related_Hypogammaglobulinemia\"><\/span>Understanding the Mechanism of CAR-T Therapy-Related Hypogammaglobulinemia<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>CAR-T therapy works by identifying and attacking cancer cells. It does so by identifying a specific protein on the surface of the B cells, which produce infection-fighting molecules called antibodies or immunoglobulins.&nbsp;<\/p>\n\n\n\n<p>Sometimes, CAR-T cells fail to differentiate cancerous B cells from healthy B cells. Consequently, they destroy both cancerous and normal B cells, leading to a low level of immunoglobulins.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"When_To_Use_IVIG_for_CAR-T_Therapy-Related_Hypogammaglobulinemia\"><\/span>When To Use IVIG for CAR-T Therapy-Related Hypogammaglobulinemia<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/ivig.jpg\" alt=\"Patient receiving IVIG for CAR-T therapy-related hypogammaglobulinemia at home\" class=\"wp-image-27789\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/ivig.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/ivig-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/ivig-18x12.jpg 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/ivig-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/ivig-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/ivig-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/ivig-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/ivig-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>IVIG is often used after CAR-T therapy to reduce infection risk and manage hypogammaglobulinemia. However, this practice lacks standardization.&nbsp;<\/p>\n\n\n\n<p>Most experts agree that IVIG for CAR-T therapy-related hypogammaglobulinemia should be considered for patients with [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8837681\/\">1<\/a>]:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>IgG \u2264 400 mg\/dl within the first 90 days after starting treatment, especially if they get serious or recurrent bacterial infections. After 90 days, IVIG may be stopped if the patient has no infection.\u00a0<\/li>\n\n\n\n<li>IgG between 400 and 600 mg\/dl who are having recurrent or serious infections.\u00a0<\/li>\n\n\n\n<li>IgG > 600 mg\/dl, but are experiencing recurrent or serious infections, and blood tests show extremely low levels of specific antibodies.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"IVIG_for_CAR-T_Therapy-Related_Hypogammaglobulinemia_in_Children\"><\/span>IVIG for CAR-T Therapy-Related Hypogammaglobulinemia in Children<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>IVIG treatment should be considered for children with IgG below 400 mg\/dl.<\/p>\n\n\n\n<p>The usual dosage of IVIG for children of all ages is 0.5 g\/kg monthly until the IgG level reaches the value considered normal for the child\u2019s age. IVIG therapy should be started 30 days after CAR T-cell infusion.&nbsp;<\/p>\n\n\n\n<p>For those with IgG between 400 and 600 mg\/dl, IVIG therapy should be considered every 3 to 4 weeks to maintain appropriate immunoglobulin levels.<\/p>\n\n\n\n<p>For children younger than 10 years, IVIG therapy should be considered if the IgG level is equal to or less than 800 mg\/dl [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8837681\/\">1<\/a>].<\/p>\n\n\n\n<p>Some health experts recommend IVIG every 3 to 4 weeks, as it may be superior to using IVIG as needed.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"IVIG_for_CAR-T_Therapy-Related_Hypogammaglobulinemia_What_Are_the_Benefits\"><\/span>IVIG for CAR-T Therapy-Related Hypogammaglobulinemia: What Are the Benefits?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>IVIG has been associated with a myriad of benefits in patients receiving CAR-T cell therapy, such as [<a href=\"https:\/\/ashpublications.org\/blood\/article\/142\/Supplement%201\/1738\/500162\/Immune-Reconstitution-and-Infection-Patterns\">3<\/a>]:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A lower rate of infections<\/li>\n\n\n\n<li>Improvement in ongoing infections<\/li>\n<\/ul>\n\n\n\n<p>IVIG may also be used to treat potentially fatal neurotoxicity associated with CAR-T therapy [<a href=\"https:\/\/www.mdpi.com\/1422-0067\/26\/8\/3904\">4<\/a>].<\/p>\n\n\n\n<div  id=\"call-to-action-a2ef9d14be8fdad5b35f9e89aab289e4\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet IVIG Copay Assistance\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span>Frequently Asked Questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h4 class=\"wp-block-heading\">1. Does IVIG treat hypogammaglobulinemia?<\/h4>\n\n\n\n<p>Yes, IVIG treats hypogammaglobulinemia by replacing <a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/immunoglobulins-ig\/\">antibodies<\/a> obtained from donors. That way, IVIG helps prevent infections in individuals who have developed hypogammaglobulinemia secondary to a cancer treatment called CAR-T therapy.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">2. Is CAR-T better than chemo?<\/h4>\n\n\n\n<p>CAR-T cell therapy was superior to chemotherapy in improving survival and was associated with a higher rate of remission among patients with treatment-resistant acute lymphoblastic leukemia. This is according to a 2018 comparative study published in the Annals of Hematology [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29417201\/\">5<\/a>].<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">3. What are the long-term side effects of CAR-T cell therapy?<\/h4>\n\n\n\n<p>The long-term side effects of CAR-T cell therapy can include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Low levels of red blood cells, white blood cells, or platelets in the blood<\/li>\n\n\n\n<li>Late infections<\/li>\n\n\n\n<li>Hypogammaglobulinemia\u00a0<\/li>\n\n\n\n<li>Neurocognitive deficits (impaired memory, attention, or thinking)<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">4. What is the death rate among patients receiving CAR-T cell therapy?<\/h4>\n\n\n\n<p>According to a 2024 study published in Nature, CAR-T therapy-related side effects were responsible for about 11% of total nonrelapse deaths [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11765209\/\">6<\/a>].<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">5. What is B-cell aplasia?<\/h4>\n\n\n\n<p>B-cell aplasia is when the blood levels of B cells (a type of white blood cell) drop too low. It happens when CAR-T cells mistakenly attack and kill healthy B cells in the body.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e34\u5e8a\u533b\u751f\u901a\u5e38\u5efa\u8bae\u4f7f\u7528\u9759\u8109\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d\uff08IVIG\uff09\u6cbb\u7597CAR-T\u7597\u6cd5\u76f8\u5173\u7684\u4f4e\u4e19\u79cd\u7403\u86cb\u767d\u8840\u75c7\uff0c\u4ee5\u964d\u4f4e\u611f\u67d3\u98ce\u9669\u5e76\u63d0\u9ad8\u751f\u5b58\u7387\u3002\u7136\u800c\uff0c\u8fd9\u4e9b\u5efa\u8bae\u7684\u89c4\u6a21\u6709\u9650\uff0c\u4e14\u57fa\u4e8e\u4e13\u5bb6\u610f\u89c1\u548c\u4e34\u5e8a\u8bd5\u9a8c\u7ed3\u679c\u3002\u00a0<\/p>","protected":false},"author":27,"featured_media":27787,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[33],"class_list":["post-27786","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-samantha-kaeberlein"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG for CAR-T Therapy-Related Hypogammaglobulinemia: Uses, Benefits, Dosage, and More - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about IVIG for CAR-T therapy-related hypogammaglobulinemia. Topics include when to use IVIG, benefits, FAQs, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG for CAR-T Therapy-Related Hypogammaglobulinemia: Uses, Benefits, Dosage, and More - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn about IVIG for CAR-T therapy-related hypogammaglobulinemia. Topics include when to use IVIG, benefits, FAQs, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-09T22:56:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-09T22:56:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/\"},\"author\":{\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\"},\"headline\":\"IVIG for CAR-T Therapy-Related Hypogammaglobulinemia: Uses, Benefits, Dosage, and More\",\"datePublished\":\"2025-09-09T22:56:18+00:00\",\"dateModified\":\"2025-09-09T22:56:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/\"},\"wordCount\":938,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/b-cells.jpg\",\"keywords\":[\"Dr. Samantha Kaeberlein\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/\",\"name\":\"IVIG for CAR-T Therapy-Related Hypogammaglobulinemia: Uses, Benefits, Dosage, and More - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/b-cells.jpg\",\"datePublished\":\"2025-09-09T22:56:18+00:00\",\"dateModified\":\"2025-09-09T22:56:20+00:00\",\"description\":\"Learn about IVIG for CAR-T therapy-related hypogammaglobulinemia. Topics include when to use IVIG, benefits, FAQs, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/b-cells.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/b-cells.jpg\",\"width\":1280,\"height\":800,\"caption\":\"B cells in someone with CAR-T Therapy-Related Hypogammaglobulinemia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG for CAR-T Therapy-Related Hypogammaglobulinemia: Uses, Benefits, Dosage, and More\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\",\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"caption\":\"Dr. Samantha Kaeberlein, PharmD\"},\"description\":\"Dr. Samantha Kaeberlein, PharmD was born and raised in Canton, OH. She received her pharmacy degree from Northeast Ohio Medical University (NEOMED) in 2020. The most rewarding part of her job is providing medical guidance so patients can make informed, well-rounded decisions regarding their healthcare. Her areas of expertise are geriatrics and long-term care. In her free time, she enjoys spending time outdoors, reading, and hunting for the best cup of coffee in America.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/author\\\/samantha\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IVIG \u7528\u4e8e\u6cbb\u7597 CAR-T \u7597\u6cd5\u76f8\u5173\u7684\u4f4e\u4e19\u79cd\u7403\u86cb\u767d\u8840\u75c7\uff1a\u7528\u9014\u3001\u76ca\u5904\u3001\u5242\u91cf\u7b49 - AmeriPharma\u00ae \u4e13\u79d1\u62a4\u7406","description":"\u4e86\u89e3 IVIG \u7528\u4e8e\u6cbb\u7597 CAR-T \u7597\u6cd5\u76f8\u5173\u4f4e\u4e19\u79cd\u7403\u86cb\u767d\u8840\u75c7\u3002\u4e3b\u9898\u5305\u62ec\u4f55\u65f6\u4f7f\u7528 IVIG\u3001\u76ca\u5904\u3001\u5e38\u89c1\u95ee\u9898\u7b49\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/","og_locale":"zh_CN","og_type":"article","og_title":"IVIG for CAR-T Therapy-Related Hypogammaglobulinemia: Uses, Benefits, Dosage, and More - AmeriPharma\u00ae Specialty Care","og_description":"Learn about IVIG for CAR-T therapy-related hypogammaglobulinemia. Topics include when to use IVIG, benefits, FAQs, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-09-09T22:56:18+00:00","article_modified_time":"2025-09-09T22:56:20+00:00","og_image":[{"width":1280,"height":800,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg","type":"image\/jpeg"}],"author":"Dr. Samantha Kaeberlein, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Samantha Kaeberlein, PharmD","Est. reading time":"5 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/"},"author":{"name":"Dr. Samantha Kaeberlein, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430"},"headline":"IVIG for CAR-T Therapy-Related Hypogammaglobulinemia: Uses, Benefits, Dosage, and More","datePublished":"2025-09-09T22:56:18+00:00","dateModified":"2025-09-09T22:56:20+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/"},"wordCount":938,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg","keywords":["Dr. Samantha Kaeberlein"],"articleSection":["IVIG"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/","url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/","name":"IVIG \u7528\u4e8e\u6cbb\u7597 CAR-T \u7597\u6cd5\u76f8\u5173\u7684\u4f4e\u4e19\u79cd\u7403\u86cb\u767d\u8840\u75c7\uff1a\u7528\u9014\u3001\u76ca\u5904\u3001\u5242\u91cf\u7b49 - AmeriPharma\u00ae \u4e13\u79d1\u62a4\u7406","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg","datePublished":"2025-09-09T22:56:18+00:00","dateModified":"2025-09-09T22:56:20+00:00","description":"\u4e86\u89e3 IVIG \u7528\u4e8e\u6cbb\u7597 CAR-T \u7597\u6cd5\u76f8\u5173\u4f4e\u4e19\u79cd\u7403\u86cb\u767d\u8840\u75c7\u3002\u4e3b\u9898\u5305\u62ec\u4f55\u65f6\u4f7f\u7528 IVIG\u3001\u76ca\u5904\u3001\u5e38\u89c1\u95ee\u9898\u7b49\u3002","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg","width":1280,"height":800,"caption":"B cells in someone with CAR-T Therapy-Related Hypogammaglobulinemia"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-car-t-therapy-related-hypogammaglobulinemia-uses-benefits-dosage-and-more\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"IVIG for CAR-T Therapy-Related Hypogammaglobulinemia: Uses, Benefits, Dosage, and More"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"AmeriPharma\u00ae \u4e13\u4e1a\u62a4\u7406","description":"AmeriPharma \u7684\u4e13\u4e1a\u62a4\u7406","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"\u7f8e\u56fd\u5236\u836f\u4e13\u4e1a\u62a4\u7406","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430","name":"Samantha Kaeberlein \u535a\u58eb\uff0c\u836f\u5b66\u535a\u58eb","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","caption":"Dr. Samantha Kaeberlein, PharmD"},"description":"Samantha Kaeberlein \u535a\u58eb\uff0c\u836f\u5b66\u535a\u58eb\uff0c\u5728\u4fc4\u4ea5\u4fc4\u5dde\u574e\u987f\u51fa\u751f\u957f\u5927\u3002\u5979\u4e8e 2020 \u5e74\u83b7\u5f97\u4e1c\u5317\u4fc4\u4ea5\u4fc4\u533b\u79d1\u5927\u5b66 (NEOMED) \u7684\u836f\u5b66\u5b66\u4f4d\u3002\u5979\u5de5\u4f5c\u4e2d\u6700\u6709\u610f\u4e49\u7684\u90e8\u5206\u662f\u63d0\u4f9b\u533b\u7597\u6307\u5bfc\uff0c\u5e2e\u52a9\u60a3\u8005\u505a\u51fa\u660e\u667a\u3001\u5168\u9762\u7684\u533b\u7597\u4fdd\u5065\u51b3\u7b56\u3002\u5979\u7684\u4e13\u4e1a\u9886\u57df\u662f\u8001\u5e74\u533b\u5b66\u548c\u957f\u671f\u62a4\u7406\u3002\u95f2\u6687\u65f6\uff0c\u5979\u559c\u6b22\u6237\u5916\u6d3b\u52a8\u3001\u9605\u8bfb\uff0c\u4ee5\u53ca\u5bfb\u627e\u7f8e\u56fd\u6700\u597d\u7684\u5496\u5561\u3002","url":"https:\/\/ameripharmaspecialty.com\/zh\/author\/samantha\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg",1280,800,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-300x188.jpg",300,188,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-768x480.jpg",768,480,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-1024x640.jpg",1024,640,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg",1280,800,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg",1280,800,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-600x375.jpg",600,375,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-86x54.jpg",86,54,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-167x104.jpg",167,104,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-280x175.jpg",280,175,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-370x231.jpg",370,231,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-960x600.jpg",960,600,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg",1280,800,false]},"uagb_author_info":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/samantha\/"},"uagb_comment_info":0,"uagb_excerpt":"Clinicians often recommend IVIG for CAR-T therapy-related hypogammaglobulinemia to reduce infection risk and improve survival. However, these recommendations are slim and based on expert opinion and clinical trial results.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg",1280,800,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg",1280,800,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg",1280,800,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-300x188.jpg",300,188,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-1024x640.jpg",1024,640,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg",1280,800,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg",1280,800,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-600x375.jpg",600,375,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-86x54.jpg",86,54,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-167x104.jpg",167,104,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-280x175.jpg",280,175,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-370x231.jpg",370,231,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells-960x600.jpg",960,600,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/09\/b-cells.jpg",1280,800,false]},"rttpg_author":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/samantha\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/zh\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"Clinicians often recommend IVIG for CAR-T therapy-related hypogammaglobulinemia to reduce infection risk and improve survival. However, these recommendations are slim and based on expert opinion and clinical trial results.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/27786","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/comments?post=27786"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/27786\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media\/27787"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media?parent=27786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/categories?post=27786"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/tags?post=27786"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}